On September 28, 2026, Boston Scientific Corp (NYSE: BSX) announced it has been awarded a $135.7 million indefinite delivery/indefinite quantity (IDIQ) contract to supply cardiovascular procedural packages and related items to the U.S. Army, Navy, and Air Force. The agreement spans five years, with orders to be fulfilled through September 29, 2031, and is funded by the Defense Working Capital Funds for fiscal years 2026 to 2031. The Defense Logistics Agency Troop Support oversees the contract.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.